Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects

NYU Alzheimer's Disease Research Center, New York

Neurological Associates of Albany, Albany

University of Rochester Medical Center, Rochester

Abington Neurological Associates, Abington

Re:Cognition Health, Fairfax

Triad Clinical Trials, Greensboro

AMC Research, Matthews

Columbus Memory Center, Columbus

Progressive Medical Research, Port Orange

K2 Medical Research, LLC, Maitland

Charter Research, Orlando

Mount Sinai Medical Center, Miami Beach

Premiere Research Institute, West Palm Beach

ALZ Research and Treatment Center (A.R.T.C.), Wellington

JEM Research Institute, Headlands Site, Atlantis

Aqualane Clinical Research, Naples

ALZ Research and Treatment Center (A.R.T.C.), Stuart

Fort Wayne Neurological Center, Fort Wayne

UT Health Science Center at Houston, Houston

Xenoscience, Inc., Phoenix

Banner Sun Health Research Institute, Sun City

Torrance Clinical Research Institute, Lomita

ATP Clinical Research, Costa Mesa

Sutter Health, Sacramento

Center for Cognitive Health, Portland

Northwest Clinical Research Center, Bellevue

Headlands Research Eastern MA, Plymouth

Advanced Memory Research Center, Toms River

Rhode Island Mood & Memory Research Institute, East Providence

OCT Research ULC (dba Okanagan Clinical Trials), Kelowna

Centricity Research, Halifax

Recherches Neuro-Hippocampe Inc., d/b/a Ottawa Memory Clinic, Ottawa

Kawartha Centre - Redefining Healthy Aging, Peterborough

Toronto Memory Program, Toronto

Re-Cognition Health Ltd Plymouth, Plymouth

Re-Cognition Health Ltd London, London

NeuroClin Glasgow Ltd, Motherwell

Re-Cognition Health Ltd Guildford, Guildford

Re-Cognition Health Ltd Birmingham, Birmingham

Re-Cognition Health Ltd Bristol, Bristol

Re-Cognition Health Ltd Winchester, Winchester